Oliai C - Search Results

1

Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.

Kennedy VE, Hui G, Azenkot T, Gaut D, Wieduwilt MJ, Oliai C, Jonas BA, Mittal V, Logan AC, Muffly LS, Mannis GN. Kennedy VE, et al. Among authors: oliai c. Am J Hematol. 2022 Jun 1;97(6):E191-E194. doi: 10.1002/ajh.26524. Epub 2022 Mar 18. Am J Hematol. 2022. PMID: 35266185 Free article. No abstract available.

2

Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.

Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD. Dolfi DV, et al. Among authors: oliai ch. J Immunol. 2011 Apr 15;186(8):4599-608. doi: 10.4049/jimmunol.1001972. Epub 2011 Mar 9. J Immunol. 2011. PMID: 21389258

3

Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia.

Levin-Epstein R, Oliai C, Schiller G. Levin-Epstein R, et al. Among authors: oliai c. Curr Treat Options Oncol. 2018 Oct 25;19(12):63. doi: 10.1007/s11864-018-0577-2. Curr Treat Options Oncol. 2018. PMID: 30362051 Review.

4

Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL.

Tabbara N, Gaut D, Oliai C, Lewis T, de Vos S. Tabbara N, et al. Among authors: oliai c. Leuk Res Rep. 2021 Jul 14;16:100260. doi: 10.1016/j.lrr.2021.100260. eCollection 2021. Leuk Res Rep. 2021. PMID: 34354920 Free PMC article.

5

Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias.

Tabbara N, Sharp J, Gaut D, Pham TTD, Tang K, Oliai C, Sim MS, Schiller G, Young P, Sasine JP. Tabbara N, et al. Among authors: oliai c. Am J Hematol. 2022 Jul;97(7):E249-E255. doi: 10.1002/ajh.26551. Epub 2022 Apr 11. Am J Hematol. 2022. PMID: 35358346 Free article. No abstract available.

6

R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Othman T, Penaloza J, Zhang S, Daniel CE, Gaut D, Oliai C, Brem EA, Baweja A, Ly J, Reid J, Pinter-Brown L, Lee M, Abdulhaq H, Tuscano J. Othman T, et al. Among authors: oliai c. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e947-e957. doi: 10.1016/j.clml.2022.06.013. Epub 2022 Jun 30. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35858904

7

Liposomal Cytarabine-Daunorubicin (CPX-351) Extravasation: Case Report and Literature Review.

Howell G, Oliai C, Schiller G. Howell G, et al. Among authors: oliai c. Anticancer Res. 2018 Dec;38(12):6927-6930. doi: 10.21873/anticanres.13070. Anticancer Res. 2018. PMID: 30504411 Review.

8

How to address second and therapy-related acute myelogenous leukaemia.

Oliai C, Schiller G. Oliai C, et al. Br J Haematol. 2020 Jan;188(1):116-128. doi: 10.1111/bjh.16354. Br J Haematol. 2020. PMID: 31863469 Free article. Review.

9

[No title available]

[No authors listed] [No authors listed] PMID: 36164225

10

Clinical features of pseudocirrhosis in metastatic breast cancer.

Oliai C, Douek ML, Rhoane C, Bhutada A, Ge PS, Runyon BA, Wang X, Hurvitz SA. Oliai C, et al. Breast Cancer Res Treat. 2019 Sep;177(2):409-417. doi: 10.1007/s10549-019-05311-y. Epub 2019 Jun 7. Breast Cancer Res Treat. 2019. PMID: 31175499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page